Skip to main navigation Skip to search Skip to main content

A Phase II multicentre trial of PF-03856884 (cvx-060), a selective angiopoietin-2 (ANG- 2) inhibitor in combination with axitinib in patients with previously treated metastatic renal cell carcinoma

  • Porfiri, Emilio (Principal Investigator)

Project Details

Short titleA Phase II multicentre trial of PF-03856884 (cvx-060), a selective angiopoietin-2 (ANG- 2) inhibitor in combination with axitinib in patients with previously treated metastatic renal cell carcinoma
StatusFinished
Effective start/end date1/11/12 → 31/07/13

Funding

  • Queen Elizabeth Hospital